Literature DB >> 17492465

The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants.

Jindrich Cinatl1, Martin Michaelis, Hans W Doerr.   

Abstract

Among emerging and re-emerging infectious diseases, influenza constitutes one of the major threats to mankind. In this review series epidemiologic, virologic and pathologic concerns raised by infections of humans with avian influenza virus A/H5N1 are discussed. This first part concentrates on epidemiologic concerns and virulence determinants. H5N1 spread over the world and caused a series of fowl pest outbreaks. Significant human-to-human transmissions have not been observed yet. Mutations that make the virus more compatible with human-to-human transmission may occur at any time. Nevertheless, no one can currently predict with certainty whether H5N1 will become a human pandemic virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492465     DOI: 10.1007/s00430-007-0042-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  67 in total

1.  Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.

Authors:  M Murakami; T Towatari; M Ohuchi; M Shiota; M Akao; Y Okumura; M A Parry; H Kido
Journal:  Eur J Biochem       Date:  2001-05

Review 2.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

Review 3.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

4.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

5.  Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.

Authors:  Elodie Ghedin; Naomi A Sengamalay; Martin Shumway; Jennifer Zaborsky; Tamara Feldblyum; Vik Subbu; David J Spiro; Jeff Sitz; Hean Koo; Pavel Bolotov; Dmitry Dernovoy; Tatiana Tatusova; Yiming Bao; Kirsten St George; Jill Taylor; David J Lipman; Claire M Fraser; Jeffery K Taubenberger; Steven L Salzberg
Journal:  Nature       Date:  2005-10-05       Impact factor: 49.962

6.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

7.  Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.

Authors:  G J D Smith; T S P Naipospos; T D Nguyen; M D de Jong; D Vijaykrishna; T B Usman; S S Hassan; T V Nguyen; T V Dao; N A Bui; Y H C Leung; C L Cheung; J M Rayner; J X Zhang; L J Zhang; L L M Poon; K S Li; V C Nguyen; T T Hien; J Farrar; R G Webster; H Chen; J S M Peiris; Y Guan
Journal:  Virology       Date:  2006-05-19       Impact factor: 3.616

8.  Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses.

Authors:  T Horimoto; K Nakayama; S P Smeekens; Y Kawaoka
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter.

Authors:  H W Doerr; Domenica Varwig; Regina Allwinn; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2006-06       Impact factor: 3.402

View more
  29 in total

Review 1.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

2.  Genetic characteristics of 2009 pandemic H1N1 influenza a viruses isolated from Mainland China.

Authors:  Jiu-Ru Zhao; Yong-Dong Li; Li-Min Pan; Na Zhu; Hong-Xia Ni; Guo-Zhang Xu; Yong-Zhong Jiang; Xi-Xiang Huo; Jun-Qiang Xu; Han Xia; Na Han; Shuang Tang; Zhong Zhang; Zheng Kou; Simon Rayner; Tian-Xian Li
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

Review 3.  The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-04       Impact factor: 3.402

Review 4.  The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-12       Impact factor: 3.402

Review 5.  The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-06-01       Impact factor: 3.402

6.  Against the new H1N1 influenza (swine influenza): vaccinate or don't vaccinate (all)? That is currently the question!

Authors:  H W Doerr; R Allwinn; J Cinatl
Journal:  Infection       Date:  2009-10       Impact factor: 3.553

7.  Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

Authors:  Sucharit Bhakdi; Karl Lackner; Hans-Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11       Impact factor: 3.402

Review 8.  Crucial role of PA in virus life cycle and host adaptation of influenza A virus.

Authors:  Jiao Hu; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2014-07-29       Impact factor: 3.402

9.  Reverse genetic platform for inactivated and live-attenuated influenza vaccine.

Authors:  Eun Ju Jung; Kwang Hee Lee; Baik Lin Seong
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

10.  Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants.

Authors:  Y Izumi; K Tokuda; Ka O'Dell; Cf Zorumski; T Narahashi
Journal:  Hum Exp Toxicol       Date:  2008-12       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.